NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.

Recs

1
Player Avatar CellBlock9 (96.36) Submitted: 8/4/2012 8:46:26 AM : Outperform Start Price: $7.37 NPSP Score: +74.28

S&P 5 star

Report this Post Reply

Featured Broker Partners


Advertisement